Price Performance of AbbVie Inc. (ABBV)
AbbVie Inc. (NYSE:ABBV) has had quite a remarkable price journey over the past year. During the past 12 months, its highest price was $122.00, which this stock reach on 02/27/18, compared to its lowest price during that period – which was $75.77 on 02/27/18.
At the end of the most recent trading day, AbbVie Inc. closed at $79.06. The stock began the trading session at $77.69 and hit a high of $79.18. The lowest price during the trading day was $76.98.
The shares of this company, which operates in the healthcare sector, reached a trading volume of about 9,077,559 throughout the day, which was clearly higher than the average daily volume for these shares.
At the time of writing, this publicly-traded organization holds a total market value of 126.81B, with 30000 employees on its payroll.
Continuing in the same vein, and taking into account all the analyst ratings for shares of AbbVie Inc. (NYSE:ABBV), the mean rating for this stock is 2.72. How is that calculated? Well, 3 analysts have given this company a BUY rating, 3 are rated it as OUTPERFORM, 9 have recommended that investors HOLD, 2 are considering it an UNDERPERFORM and 1 has recommended that owners of these shares SELL.
A month ago, 4 analysts thought this stock was a BUY, 4 of them posted an OUTPERFORM rating, 8 analysts recommended to HOLD this stock, 2 of them provided an underperform rating and 1 rated it as a Sell.
For ABBV stock, the reported Earnings Per Share trailing twelve months is sitting at -2.40%. Meanwhile, operating margin is currently observed to be 31.60% and its Gross Margin trailing twelve months is 76.30%.
This company’s 100-day moving average was 88.54, while its price change was posted at -16.13. Similarly, AbbVie Inc. (NYSE:ABBV) experienced a 100-day Percent movement of -16.95% with a trading volume reaching 6,849,308.
Continuing to look at similarly important data, this stock’s distance from its 200-day Simple Moving Average, or SMA 200, is -14.89% at the time of writing. This organization’s revenue over the trailing twelve months (TTM) of active operations is 32.19B, considering the fact that it was able to rack up the income of $7.93B through that period of time.
While maintaining our attention on the Technical analysis of AbbVie Inc. (NYSE:ABBV), during the last 50 days, its Raw Stochastic average was observed 17.13%, representing a downgrade from this organization’s 20-day Raw Stochastic average – which was posted 19.90%. During the last 20-days time span, this firm’s Stochastic %K was 10.87% and its Stochastic %D was noted 9.03%.
We can take a look at observable moving trends AbbVie Inc. (NYSE:ABBV) stock by taking a deep at its previous price journey. This particular stock’s current year-to-date (YTD) price performance is standing at -14.24%. Meanwhile, during the past six months of trading, this stock has deteriorated to -13.55%, along with a full-year performance of -35.36%. This company’s shares increased nearly 1.88% during the last 7-day stretch and up -10.62% over the last 30 days.